Total number of deaths by eGFR status 25[OH]D groups.

<p>Total number of deaths by eGFR status 25[OH]D groups.</p

All-cause mortality rate per 1000 person-years (95% CI) and mortality rate ratios by 25[OH]D groups among participants with e GFR≥60 ml/min/1.73 m².

*<p>All-cause mortality rate per 1000 person-years.</p><p>Model adjusts for age, sex, race/ethnicity, season of 25[OH]D measurement, co-morbidities (cancer, MI, CHF, stroke, diabetes), BMI, SBP, eGFR, smoking, medication use and educational level.</p

All-cause mortality rate per 1000 Person-Years (95% CI) and mortality rate ratios by 25[OH]D groups among participants with eGFR<60 ml/min/1.73 m².

*<p>All-cause mortality rate per 1000 person-years.</p><p>Model adjusts for age, sex, race/ethnicity, season of 25[OH]D measurement, co-morbidities, BMI, SBP, eGFR, smoking, medication use and educational level.</p

Flowchart of individuals included in the analysis of the association between 25[OH]D and all-cause mortality.

<p>Flowchart of individuals included in the analysis of the association between 25[OH]D and all-cause mortality.</p

Age-, sex-, season- and race/ethnicity-adjusted mortality rates per 1,000 person-years by 25(OH)D groups among adults with eGFR <60 ml/min/1.73 m².

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047458#pone-0047458-g002" target="_blank">Figure 2</a> includes all participants (with eGFR <60 ml/min/1.73 m²) and under 3 exclusion strategies: 1) Exclusion of participants who died within one year of baseline examination; 2) Exclusion of participants who died within two years of baseline examination; 3) Exclusion of participants who died within three years of baseline examination. Rates were computed using Poisson regression analysis after grouping 25[OH] D values into 7 groups.</p

Baseline characteristics of study participants with eGFR<60 ml/min/1.73 m² by 25[OH]D groups.

*<p>Data are shown as mean (standard error) or percentages (standard error).</p

Age-, sex-, season- and race/ethnicity-adjusted mortality rates per 1,000 person-years by 25(OH)D groups among adults without eGFR <60 ml/min/1.73 m².

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047458#pone-0047458-g003" target="_blank">Figure 3</a> includes all participants (without eGFR <60 ml/min/1.73 m²) and under 3 exclusion strategies: 1) Exclusion of participants who died within one year of baseline examination; 2) Exclusion of participants who died within two years of baseline examination; 3) Exclusion of participants who died within three years of baseline examination. Rates were computed using Poisson regression analysis after grouping 25[OH] D values into 7 groups.</p

Baseline characteristics of adults with eGFR ≥60 ml/min/1.73 m² by 25(OH)D groups.

<p>Baseline characteristics of adults with eGFR ≥60 ml/min/1.73 m² by 25(OH)D groups.</p

Distribution of attributes, National Health and Nutrition Examination Survey 1999–2004, overall and by albuminuria status.

<p>P values use t-test for differences in means, and Wald chi-square test for proportions.</p>*<p>Note that values in the table are weighted to take into account the complex survey design; however, the counts of number of subjects with (n = 1326) and without albuminuria (n = 8032) are not weighted for the survey design.</p>†<p>Triglyceride levels available only for the subset (n = 4457) with fasting morning blood draw.</p

Adjusted Odds Ratios (aORs) comparing albuminuria among consumers of 2+ vs. 0–1 sugary soft drinks per day, according to interaction with body mass index (BMI).

<p>Adjusted for diet soda consumption, age, race, ethnicity, poverty status, BMI, and BMI-squared.</p